Literature DB >> 1521137

Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex.

M M Mesulam1, C Geula.   

Abstract

The distribution of acetylcholinesterase-rich axons was compared to that of choline acetyltransferase-positive (cholinergic) axons in 28 major cytoarchitectonic divisions of the adult human cerebral cortex. Acetylcholinesterase-rich as well as choline acetyltransferase-positive cortical axons contained multiple varicosities. Each type of axon was more densely distributed in limbic-paralimbic regions of the brain. In all the cortical areas that were examined, the two markers displayed laminar and regional distribution patterns that were indistinguishable from each other. A method that allowed the concurrent visualization of both reaction products demonstrated that acetylcholinesterase and choline acetyltransferase were colocalized in the same axon. These observations show that there is probably a complete correspondence between choline acetyltransferase-positive and acetylcholinesterase-rich axons and that the acetylcholinesterase reaction can be used as a specific marker for cortical cholinergic axons in the adult human brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521137     DOI: 10.1016/0006-8993(92)90543-i

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Differential maturation of vesicular glutamate and GABA transporter expression in the mouse auditory forebrain during the first weeks of hearing.

Authors:  Troy A Hackett; Amanda R Clause; Toru Takahata; Nicholas J Hackett; Daniel B Polley
Journal:  Brain Struct Funct       Date:  2015-07-10       Impact factor: 3.270

2.  Neuronal and axonal loss are selectively linked to fibrillar amyloid-{beta} within plaques of the aged primate cerebral cortex.

Authors:  Palak Shah; Neeta Lal; Elaine Leung; David E Traul; Alicia Gonzalo-Ruiz; Changiz Geula
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

3.  Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system.

Authors:  O Miyamoto; J Minami; T Toyoshima; T Nakamura; T Masada; S Nagao; T Negi; T Itano; A Okabe
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Pedunculopontine Nucleus Cholinergic Deficiency in Cervical Dystonia.

Authors:  Karin Mente; Nancy A Edwards; Demelio Urbano; Abhik Ray-Chaudhury; Diego Iacono; Ana Tereza Di Lorenzo Alho; Eduardo Joaquim Lopes Alho; Edson Amaro; Silvina G Horovitz; Mark Hallett
Journal:  Mov Disord       Date:  2018-03-06       Impact factor: 10.338

Review 5.  Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease.

Authors:  M-Marsel Mesulam
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

Review 6.  The application of positron-emitting molecular imaging tracers in Alzheimer's disease.

Authors:  Robert M Cohen
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

7.  Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections.

Authors:  N I Bohnen; C W Bogan; M L T M Müller
Journal:  Eur Neurol J       Date:  2009-09

8.  In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease.

Authors:  Nobuyuki Okamura; Yoshihito Funaki; Manabu Tashiro; Motohisa Kato; Yoichi Ishikawa; Masahiro Maruyama; Hiroyasu Ishikawa; Kenichi Meguro; Ren Iwata; Kazuhiko Yanai
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

Review 9.  The cholinergic system and Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Behav Brain Res       Date:  2010-01-07       Impact factor: 3.332

10.  Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease.

Authors:  Changiz Geula; Nicholas Nagykery; Alexander Nicholas; Chuang-Kuo Wu
Journal:  J Neuropathol Exp Neurol       Date:  2008-04       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.